Boulding Mark Elliott's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Feb 23, 2026
- Accession no.
- 0001578852-26-000010
- Filed
- Feb 23, 2026
- Trade date
- Feb 19, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $209.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boulding Mark ElliottCIK 0001578852 | Officer (EXEC. VP AND CLO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Common Stock | SSaleDisposed | −588 | $68.54F2 | −$40,301.52 | 107,643 | Direct | |
| Feb 19, 2026 | Common Stock | SSaleDisposed | −1,629 | $69.82F3 | −$113,736.78 | 106,014 | Direct | |
| Feb 19, 2026 | Common Stock | SSaleDisposed | −212 | $68.54F2 | −$14,530.48 | 105,802 | Direct | |
| Feb 19, 2026 | Common Stock | SSaleDisposed | −590 | $69.82F3 | −$41,193.8 | 105,212 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $67.99 to $68.93 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 2 transactions in Table I.
- F3
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $69.52 to $70.18 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 2 transactions in Table I.